BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36249202)

  • 21. Cost Effectiveness of Lung Cancer Screening With Low-Dose CT in Heavy Smokers in China.
    Yuan J; Sun Y; Wang K; Wang Z; Li D; Fan M; Bu X; Chen M; Ren H
    Cancer Prev Res (Phila); 2022 Jan; 15(1):37-44. PubMed ID: 34580085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    Lung Cancer; 2016 Nov; 101():98-103. PubMed ID: 27794416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-Effectiveness of Lung Cancer Screening Using Low-Dose Computed Tomography Based on Start Age and Interval in China: Modeling Study.
    Zhao Z; Du L; Li Y; Wang L; Wang Y; Yang Y; Dong H
    JMIR Public Health Surveill; 2022 Jul; 8(7):e36425. PubMed ID: 35793127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions.
    Villanti AC; Jiang Y; Abrams DB; Pyenson BS
    PLoS One; 2013; 8(8):e71379. PubMed ID: 23940744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-Effectiveness Analysis of Risk Factor-Based Lung Cancer Screening Program by Low-Dose Computer Tomography in Current Smokers in China.
    Zhang T; Chen X; Li C; Wen X; Lin T; Huang J; He J; Zhong N; Jiang J; Liang W
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of baseline low-dose computed tomography screening for lung cancer: the Israeli experience.
    Shmueli A; Fraifeld S; Peretz T; Gutfeld O; Gips M; Sosna J; Shaham D
    Value Health; 2013; 16(6):922-31. PubMed ID: 24041342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.
    Li N; Tan F; Chen W; Dai M; Wang F; Shen S; Tang W; Li J; Yu Y; Cao W; Xu Y; Qin C; Zhao L; Zhu M; Guo L; Wu Z; Yang Z; Zheng Y; Chen H; Liu Y; Wei D; Dong D; Cao J; Zhang S; Yan S; Wang N; Du L; Shen H; Wu N; He J;
    Lancet Respir Med; 2022 Apr; 10(4):378-391. PubMed ID: 35276087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can we increase efficiency of CT lung cancer screening by combining with CVD and COPD screening? Results of an early economic evaluation.
    Behr CM; Koffijberg H; Degeling K; Vliegenthart R; IJzerman MJ
    Eur Radiol; 2022 May; 32(5):3067-3075. PubMed ID: 34973103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of Lung Cancer Screening in Canada.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    JAMA Oncol; 2015 Sep; 1(6):807-13. PubMed ID: 26226181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan.
    Yang SC; Lai WW; Lin CC; Su WC; Ku LJ; Hwang JS; Wang JD
    Lung Cancer; 2017 Jun; 108():183-191. PubMed ID: 28625633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of lung cancer screening with low-dose computed tomography in heavy smokers: a microsimulation modelling study.
    Du Y; Sidorenkov G; Heuvelmans MA; Groen HJM; Vermeulen KM; Greuter MJW; de Bock GH
    Eur J Cancer; 2020 Aug; 135():121-129. PubMed ID: 32563896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimated Cost-effectiveness of Endoscopic Screening for Upper Gastrointestinal Tract Cancer in High-Risk Areas in China.
    Xia R; Zeng H; Liu W; Xie L; Shen M; Li P; Li H; Wei W; Chen W; Zhuang G
    JAMA Netw Open; 2021 Aug; 4(8):e2121403. PubMed ID: 34402889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review.
    Raymakers AJN; Mayo J; Lam S; FitzGerald JM; Whitehurst DGT; Lynd LD
    Appl Health Econ Health Policy; 2016 Aug; 14(4):409-418. PubMed ID: 26873091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing the downstream costs and healthcare utilization associated with the use of low-dose computed tomography (LDCT) in lung cancer screening in patients with and without alzheimer's disease and related dementias (ADRD).
    Zhang Y; Bian J; Huo J; Yang S; Guo Y; Shao H
    Curr Med Res Opin; 2021 Oct; 37(10):1731-1737. PubMed ID: 34252317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening.
    Pastorino U; Sverzellati N; Sestini S; Silva M; Sabia F; Boeri M; Cantarutti A; Sozzi G; Corrao G; Marchianò A
    Eur J Cancer; 2019 Sep; 118():142-148. PubMed ID: 31336289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study.
    Wei MN; Su Z; Wang JN; Gonzalez Mendez MJ; Yu XY; Liang H; Zhou QH; Fan YG; Qiao YL
    Thorac Cancer; 2020 May; 11(5):1224-1232. PubMed ID: 32196998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung cancer screening by low-dose computed tomography: a cost-effectiveness analysis of alternative programmes in the UK using a newly developed natural history-based economic model.
    Griffin E; Hyde C; Long L; Varley-Campbell J; Coelho H; Robinson S; Snowsill T
    Diagn Progn Res; 2020 Dec; 4(1):20. PubMed ID: 33292800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of low-dose computed tomography screening on lung cancer mortality among asbestos-exposed workers.
    Barbone F; Barbiero F; Belvedere O; Rosolen V; Giangreco M; Zanin T; Pisa FE; Meduri S; Follador A; Grossi F; Fasola G
    Int J Epidemiol; 2018 Dec; 47(6):1981-1991. PubMed ID: 30325420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opportunistic Screening With Low-Dose Computed Tomography and Lung Cancer Mortality in China.
    Wang L; Qi Y; Liu A; Guo X; Sun S; Zhang L; Ji H; Liu G; Zhao H; Jiang Y; Li J; Song C; Yu X; Yang L; Yu J; Feng H; Yang F; Xue F
    JAMA Netw Open; 2023 Dec; 6(12):e2347176. PubMed ID: 38085543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.